-
effectivehealthcare-admin.ahrq.gov/products/atherosclerosis-plaque/technical-brief
December 01, 2019 - Web Version (NLM Site
-
effectivehealthcare-admin.ahrq.gov/products/high-cholestorol-medications/research
December 01, 2019 - Web Version (NLM Site
-
effectivehealthcare-admin.ahrq.gov/products/prostate-cancer/research
December 01, 2019 - Web Version (NLM Site
-
effectivehealthcare-admin.ahrq.gov/products/breast-abnormalities-tests/research
December 01, 2019 - Web Version (NLM Site
-
effectivehealthcare-admin.ahrq.gov/products/antipsychotics-children-future/research
December 01, 2019 - Web Version (NLM Site
-
effectivehealthcare-admin.ahrq.gov/products/cancer-anemia/research
December 01, 2019 - Web Version (NLM Site
-
effectivehealthcare-admin.ahrq.gov/products/atypical-antipsychotics-off-label/research
December 01, 2019 - Web Version (NLM Site
-
effectivehealthcare-admin.ahrq.gov/products/ace-inhibitor-arb-2007/research-2007-1
December 01, 2019 - Web Version (NLM Site
-
effectivehealthcare-admin.ahrq.gov/products/type-2-diabetes-medications-2007/research
December 01, 2019 - Web Version (NLM Site
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-485-09-03-2013.pdf
January 01, 2013 - If this topic is developed into a technical brief, the protocol will be posted on the AHRQ Web site
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0496_12-30-2011.pdf
January 01, 2011 - When key questions have been drafted, they will be posted on the AHRQ Web site and open for public
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0416_02-18-2011.pdf
January 01, 2011 - When key questions have been drafted, they will be posted on the AHRQ Web site and open for public
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0407_01-20-2011.pdf
January 01, 2011 - When key questions have been drafted, they will be posted on the AHRQ Web site and open for public
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0264_01-14-2008.pdf
January 01, 2008 - When key questions have been drafted, they will be posted on the AHRQ Web site and open for
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-0543_05-24-2013.pdf
January 01, 2013 - When key questions have been drafted, they will be posted on the AHRQ Web site and open for public
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0477_11-01-2011.pdf
January 01, 2011 - When key questions have been drafted, they will be posted on the AHRQ Web site and open for public
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-0663-131114.pdf
April 10, 2013 - When key questions have been drafted, they will be posted on the AHRQ Web site and open for public
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ischemic-stroke-treatment_research-protocol.pdf
February 19, 2010 - plasminogen activator (alteplase,
rtPA), restore cerebral perfusion by activating plasminogen at the site … percent during the initial 6 to 24 hours after treatment.22 Recanalization rates vary
depending on the site … breakage/fracture, perforation, dissection, thrombus formation proximal,
adjacent, or distal to the clot site … breakage/fracture,
perforation, dissection, thrombus formation proximal, adjacent, or distal to the clot site … breakage/fracture, perforation, dissection, thrombus formation (proximal, adjacent, or distal to
the clot site
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0368_11-08-2010.pdf
January 01, 2010 - When key questions have been drafted, they will be posted on the AHRQ Web site and open for public
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-0495_05-24-2013.pdf
January 01, 2013 - technical brief, the protocol and key questions will be drafted and posted
on the EHC Program Web site